Search Results 11-20 of 16404 for Proto-oncogene
That's according to new Mayo Clinic research. The findings, published this month in Oncogene, indicate that increasing the expression of the PD-L1 protein in ...
Found PKCiota activates a second oncogene, known as SOX2, to stimulate cancer stem cell growth in lung squamous cell carcinoma. Dr. Fields says the current ...
However, the presence of oncogenic signaling (Kras mutations, EGF-R) can push these duct cells to develop lesions that are at risk for tumor development. To ...
(ALK), B-Raf proto-oncogene (BRAF) or ROS proto-oncogene 1 (ROS1) mutations who have not received appropriate therapies targeting these mutations and ...
A different member of the cyclin family — cyclin A2 — is a well-known oncogene, but, before this study, no one had shown that cyclin A1 does the same thing ...
Clinical and therapeutic relevance of the metabolic oncogene fatty acid synthase in HER2+ breast cancer. Histol Histopathol. 2017 Jul; 32 (7):687-698 Epub ...
The lab team has confirmed activation of this signaling pathway by oncogenic KRas as a key event driving the development of pancreatic cancer. The lab's ...
The neu (c-erbB-2) proto-oncogene encodes a tyrosine kinase receptor that is overexpressed in 20 to 30% of human breast tumors. Herein, cyclin D1 protein ...
Cancer biology. CRISPR-based approaches help investigate tumor suppressors, oncogenes and drug resistance mechanisms. Cell therapy. Precision gene editing ...
... proto-oncogene, and proto-oncogene B-RAF. Patients who have a single, operable brain metastasis. Patients with significant edema leading to risk of brain ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.